GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » Inventories, Raw Materials & Components

Defence Therapeutics (XCNQ:DTC) Inventories, Raw Materials & Components : C$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Inventories, Raw Materials & Components?

Defence Therapeutics's inventories, raw materials & components for the quarter that ended in Dec. 2023 was C$0.00 Mil.


Defence Therapeutics Inventories, Raw Materials & Components Historical Data

The historical data trend for Defence Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Inventories, Raw Materials & Components Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22
Inventories, Raw Materials & Components
- - -

Defence Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Defence Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Defence Therapeutics (XCNQ:DTC) Business Description

Industry
Traded in Other Exchanges
Address
200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.